Burkitt lymphoma and atypical Burkitt or Burkitt-like lymphoma: should these be treated as different diseases? (Q35384536)

8 August 2017

1 reference

title

Burkitt lymphoma and atypical Burkitt or Burkitt-like lymphoma: should these be treated as different diseases? (English)

1 reference

8 August 2017

0 references

Hagop Kantarjian

1 reference

8 August 2017

Stefan Faderl

1 reference

8 August 2017

Jorge Cortes

1 reference

8 August 2017

Susan O'Brien

1 reference

8 August 2017

Luis Fayad

0 references

Fredrick B Hagemeister

object named as

Fredrick Hagemeister

1 reference

8 August 2017

Deborah A Thomas

1 reference

8 August 2017

John T Manning

1 reference

8 August 2017

Jorge Romaguera

1 reference

8 August 2017

Jeffrey Medeiros

1 reference

8 August 2017

publication date

1 March 2011

1 reference

Current hematologic malignancy reports

8 August 2017

1 reference

inferred from page(s)

published in

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

8 August 2017

page(s)

58-66

1 reference

B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology.

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4394740

B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4394740

Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4394740

Commentary on the WHO classification of tumors of lymphoid tissues (2008): "Gray zone" lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4394740

A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4394740

Spectrum of Epstein-Barr virus-associated diseases

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4394740

Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4394740

Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4394740

Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4394740

Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4394740

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4394740

Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4394740

The discovery of Burkitt's lymphoma

27 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-010-0076-4

Adult Burkitt leukemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-010-0076-4

Molecular heterogeneity of sporadic adult Burkitt-type leukemia/lymphoma as revealed by PCR and cytogenetics: correlation with morphology, immunology and clinical features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-010-0076-4

Advances in the understanding of MYC-induced lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-010-0076-4

Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-010-0076-4

Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-010-0076-4

Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-010-0076-4

Molecular diagnosis of Burkitt's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-010-0076-4

A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-010-0076-4

Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-010-0076-4

An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-010-0076-4

Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-010-0076-4

Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-010-0076-4

Burkitt lymphoma/leukemia: improving prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-010-0076-4

High-grade mature B-cell lymphoma with Burkitt-like morphology: results of a clinicopathological study of 72 Japanese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-010-0076-4

"Double-Hit" mature B-cell lymphomas show a common immunophenotype by flow cytometry that includes decreased CD20 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-010-0076-4

Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-010-0076-4

The 2008 WHO classification of lymphomas: implications for clinical practice and translational research.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4394740

Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4394740

Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4394740

Improved outcome in adult B-cell acute lymphoblastic leukemia

26 September 2018

1 reference

12 December 2020

Combination of t(14;18) and a Burkitt's type translocation in B-cell malignancies

1 reference

12 December 2020

The spectrum of lymphoma with 8q24 aberrations: a clinical, pathological and cytogenetic study of 87 consecutive cases

1 reference

12 December 2020

The spectrum of B-cell non-Hodgkin lymphomas with dual IgH-BCL2 and BCL6 translocations

1 reference

12 December 2020

The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features

1 reference

12 December 2020

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

1 reference

12 December 2020

Germinal center and activated b-cell profiles separate Burkitt lymphoma and diffuse large B-cell lymphoma in AIDS and non-AIDS cases

1 reference

12 December 2020

High-grade B-cell lymphoma/leukemia associated with t(14;18) and 8q24/MYC rearrangement: a neoplasm of germinal center immunophenotype with poor prognosis

1 reference

12 December 2020

Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis

1 reference

12 December 2020

10.1007/S11899-010-0076-4

Identifiers

DOI

1 reference

8 August 2017

1 reference

8 August 2017

1 reference